Pumitamig — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

9 Recruiting

0 Completed trials

2 Sponsors

18 Countries

Phase III

Phase II/III

Phase II

Phase I/II

Phase III: 3 Phase II/III: 2 Phase II: 1 Phase I/II: 4

Indications tested

Non-small cell lung cancer metastatic 2 Non-small cell lung cancer 2 Non-small cell lung cancer stage III 1 Squamous cell carcinoma of lung 1 Breast cancer 1 HER2 mutant non-small cell lung cancer 1 Non-small cell lung cancer recurrent 1 Non-small cell lung cancer stage IV 1 Gastric cancer 1 Non-small cell lung cancer stage IIIB 1 Colorectal cancer metastatic 1 Non-small cell lung cancer stage IIIA 1

Sponsors using this IMP

Bristol-Myers Squibb Services Unlimited Company 6 BioNTech SE 4

All trials

10 total

A study of BMS-986504 as Monotherapy and in Combination with Other Agents in Participants with Advanced and/or Metastatic Solid Tumors with … Pending

2025-524285-18-00 Phase II 2 countries Bristol-Myers Squibb Services Unlimited Company
A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Recruiting

2025-523576-23-00 Phase III 14 countries Bristol-Myers Squibb Services Unlimited Company
A Study of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50% Recruiting

2025-523586-18-00 Phase III 16 countries Bristol-Myers Squibb Services Unlimited Company
ROSETTA Breast-01: The effects and safety of pumitamig in patients with triple-negative breast cancer Recruiting

2025-521884-12-00 Phase III 8 countries BioNTech SE
A Phase 1/2 Study of Pumitamig alone or in Combination with Ipilimumab in First-Line HCC Recruiting

2025-523602-33-00 Phase I/II 5 countries Bristol-Myers Squibb Services Unlimited Company
Study of Pumitamig in Combination with Chemotherapy Versus Nivolumab in Combination with Chemotherapy in Previously Untreated Advanced or Me… Recruiting

2025-523263-37-00 Phase II/III 6 countries Bristol-Myers Squibb Services Unlimited Company
Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Previously Untreated, Unresectable, or Met… Recruiting

2025-523224-45-00 Phase II/III 11 countries Bristol-Myers Squibb Services Unlimited Company
A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with… Recruiting

2024-519344-32-00 Phase I/II 4 countries BioNTech SE
A clinical study to test if an investigational treatment called BNT314 when used in combination with another investigational treatment pumit… Recruiting

2025-521768-36-00 Phase I/II 2 countries BioNTech SE
A clinical study to test if an investigational treatment called BNT326 is safe and potentially beneficial when used alone or in combination … Recruiting

2024-517261-16-00 Phase I/II 4 countries BioNTech SE

Showing 1–10 of 10 trials

← All drugs A–Z